Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT01712646
Show Display Options
Rank Status Study
1 Terminated Daily Intranasal Oxytocin for Childhood-Onset Schizophrenia
Conditions: Childhood Onset Psychotic Disorders;   Schizophrenia
Intervention: Drug: Intranasal Oxytocin

Study has passed its completion date and status has not been verified in more than two years.